Voloridge Investment Management Portfolio holdings
AUM
$27.1B
1-Year Return
25.54%
This Quarter Return
-2.57%
1 Year Return
+25.54%
3 Year Return
+79.26%
5 Year Return
+135.5%
10 Year Return
+413.11%
AUM
$27B
AUM Growth
-$1.24B
(-4.4%)
Cap. Flow
-$254M
Cap. Flow
% of AUM
-0.94%
Top 10 Holdings %
Top 10 Hldgs %
8.79%
Holding
1,413
New
263
Increased
441
Reduced
444
Closed
265
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$285M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$191M |
| 3 |
Home Depot
HD
|
+$166M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$144M |
| 5 |
Eaton
ETN
|
+$128M |
Top Sells
| 1 |
Cigna
CI
|
+$206M |
| 2 |
NVIDIA
NVDA
|
+$201M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$199M |
| 4 |
Booking.com
BKNG
|
+$191M |
| 5 |
Elevance Health
ELV
|
+$178M |
Sector Composition
| 1 | Technology | 16.43% |
| 2 | Financials | 15.81% |
| 3 | Consumer Discretionary | 15.45% |
| 4 | Industrials | 14.93% |
| 5 | Healthcare | 12.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Dentsply Sirona
XRAY
$2.81B
| $22M | 0.08% |
1,471,184
+176,595
| +14% | +$2.64M |
|
327
UnitedHealth
UNH
$303B
| $21.9M | 0.08% |
41,909
-51,097
| -55% | -$26.8M |
|
|
ANSS
328
DELISTED
Ansys
ANSS
| $21.9M | 0.08% |
69,304
+21,865
| +46% | +$6.92M |
|
329
Taylor Morrison
TMHC
$6.86B
| $21.9M | 0.08% |
364,550
+198,916
| +120% | +$11.9M |
|
330
Mobileye
MBLY
$12.2B
| $21.5M | 0.08% |
1,493,681
+77,257
| +5% | +$1.11M |
|
331
Bread Financial
BFH
$3.05B
| $21.5M | 0.08% |
428,389
+76,784
| +22% | +$3.85M |
|
332
Lamar Advertising Co
LAMR
$13B
| $21.4M | 0.08% |
188,515
+122,870
| +187% | +$14M |
|
333
Performance Food Group
PFGC
$16.1B
| $21.4M | 0.08% |
272,434
+12,716
| +5% | +$1,000K |
|
334
Progyny
PGNY
$1.96B
| $21.4M | 0.08% |
958,151
-239,842
| -20% | -$5.36M |
|
335
Unity
U
$19.2B
| $21.4M | 0.08% |
+1,092,090
| New | +$21.4M |
|
336
New York Times
NYT
$9.47B
| $21.4M | 0.08% |
+430,956
| New | +$21.4M |
|
337
SM Energy
SM
$3.07B
| $21.3M | 0.08% |
710,865
-463,866
| -39% | -$13.9M |
|
338
CDW
CDW
$22.2B
| $21.3M | 0.08% |
132,746
-474,614
| -78% | -$76.1M |
|
339
Travere Therapeutics
TVTX
$1.87B
| $21.2M | 0.08% |
1,181,094
+173,897
| +17% | +$3.12M |
|
|
FLG
340
Flagstar Financial, Inc.
FLG
$5.32B
| $21.1M | 0.08% |
+1,817,748
| New | +$21.1M |
|
341
Idexx Laboratories
IDXX
$52B
| $21M | 0.08% |
50,032
-108,479
| -68% | -$45.6M |
|
|
PDCO
342
DELISTED
Patterson Companies, Inc.
PDCO
| $20.9M | 0.08% |
667,751
+17,026
| +3% | +$532K |
|
343
Brookfield Renewable
BEPC
$6.05B
| $20.8M | 0.08% |
745,583
+77,487
| +12% | +$2.16M |
|
344
Manhattan Associates
MANH
$13.1B
| $20.8M | 0.08% |
+120,232
| New | +$20.8M |
|
345
Corcept Therapeutics
CORT
$7.47B
| $20.7M | 0.08% |
181,571
-290,052
| -62% | -$33.1M |
|
|
PYCR
346
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $20.7M | 0.08% |
923,613
+571,721
| +162% | +$12.8M |
|
347
Nova
NVMI
$8.24B
| $20.7M | 0.08% |
112,339
-54,751
| -33% | -$10.1M |
|
348
PNC Financial Services
PNC
$80B
| $20.7M | 0.08% |
+117,700
| New | +$20.7M |
|
349
Nordson
NDSN
$12.5B
| $20.6M | 0.08% |
102,093
-35,963
| -26% | -$7.25M |
|
350
Charles River Laboratories
CRL
$7.76B
| $20.6M | 0.08% |
136,735
-19,839
| -13% | -$2.99M |
|